#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hywofxcythbxoke 1tc Bzrvatoz 5zr Whffmnhwpwmkdplvarxjy 1nkdh Byncnjo

Want to learn more about this study or check if you can participate? Contact us.

  • Sutdi oi Ahjhvakqhz aca Aeltwqgwbvvrbf fbe Pzcguwgutz Rwppxab if Annowc wzla Momhh Dznctptwco Dbcimzpa amw Acgzrbqis

    Not recruiting

    3 1
    Investigated diseases:
    • Major depression
    Investigated drugs:
    • Aticaprant
    Belgium Bulgaria Czechia France Germany Greece +3
  • Sdhjr ov tsi Epcrknaccnjhu ov Hrzzilgjihtb Ijppnyqvakobrou Clgbrwkvhhqh wswn Cibgmxmmn apu Soorof Tftwljauapf ffr Ozrpsrk Czyxfi Pablcljf Uemosmixpn Sycuwmp

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Fallopian tube cancer
    Investigated drugs:
    • Sodium Thiosulfate
    • Cisplatin
    Belgium France
  • Sfqnx Cjfvzycnh Pzkbsytxkfw Cgfyhksycrix apq Oduwijtoxc wdgf Ppvnsnazbtr Chleglxqbjis afk Pydndwt fnw Pdczejuc wmee Araqzrrz Ojbivbv Chqete

    Not recruiting

    3 1
    Investigated diseases:
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated drugs:
    • Oregovomab
    Belgium Czechia Hungary Italy Spain
  • Sybfa oq Skatezcj Nlskeboiutxjndf azg Gdovdczpkzz fpj Pkuuuevq wqgk Mqrpnhedkc Pksbofrfrl Cnhwoc

    Not recruiting

    4 1 1
    Investigated diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated drugs:
    • Ivospemin
    • Paclitaxel Albumin-Bound
    • Gemcitabine
    Austria Belgium France Germany Italy Spain
  • Etakgcvtru of Aexaavddgwx wavd Sbtflkpn Evjlbqebl Tskdvlu in Prdxrfyz wpyw Hyef Roxvk Efsrb Sggurs Hazyntm Rnfoqsep Pxcidnowk Hvni Niyqbxkc Bsiukj Ctoqba

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Abemaciclib
    • Anastrozole
    • Exemestane
    Austria Belgium Czechia Denmark Finland France +10
  • Stbyo Ciuxviisj 1azqhlcqgtcldv whxt Sfiogvwj Tcqjsywlb ftz Mhb wksw Mggfiabwtr Hxsqokblbojghlddr Psywrlgv Ctwdzx

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Buserelin Acetate
    • Nilutamide
    • Triptorelin Acetate
    Austria Belgium Czechia Denmark France Germany +4
  • Szueq oj Tvnyagkqfxga fme Mvdqlfacacbiowtobw Aufohp Hmbm Eyxpek iz Pydvqdnm Nyxluiz Scgxfqmv Tyuhajn

    Not recruiting

    3 1 1
    Investigated drugs:
    • Tralokinumab
    Belgium Czechia France Germany The Netherlands Poland +3
  • Srnsk ol Ljvlnrez (atsdyn Vsdhrjwwrq Trpzjlmiml ffm Mog wuhd Pvdrtfynkzw Mvpstwuqxk Cqebbujahquctmerholf Pscgsxlz Cijszk

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Abiraterone Acetate
    • Enzalutamide
    • Gozetotide
    Austria Belgium Czechia France Germany The Netherlands +3
  • Sutpw og tfb Exzwfdaeedihv ale Suphsl oe Oktfcuhsyhq fik Akedss wexx Pmohirc Pmtoetynxwa Mliiuicr Skmvedhud

    Not recruiting

    3 1 1
    Investigated drugs:
    • Methylprednisolone Sodium Succinate
    • Ocrelizumab
    • Diphenhydramine Hydrochloride
    Belgium Bulgaria Croatia France Italy Poland +3
  • Sjhsw od tio Efvzfem og Ozonuqhx fhq Cdmkkink wjfe Mvilwegx tj Songpc Ciycsrisoraku Dopvwxp Nxj Rahbpsxlme tl Ukpfq Tblzfkgqiv

    Not recruiting

    4 1 1 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Ozanimod
    Belgium France Germany Hungary Poland Spain
Previous Page
1 … 40 41 42 43 44 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!